Simone Meier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Simone Meier has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Jochen Brich
University of Freiburg
6 shared publications - Diana Rau
University of Freiburg
5 shared publications - Erik Farin-Glattacker
Section of Health Care Research and Rehabilitation Research, Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany
5 shared publications - Florian Schuchardt
Department of Neurology and Neurophysiology, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
5 shared publications - Matthias L. Herrmann
Department of Neurology and Clinical Neuroscience, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany
5 shared publications - Nicole Wimmesberger
Sektion Versorgungsforschung und Rehabilitationsforschung, Institut für Medizinische Biometrie und Statistik, Universitätsklinikum Freiburg, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Deutschland
4 shared publications
Latest Publications
- Open Access
- 16 April 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13 (1) , e58180
Correction: Identification of Anterior Large Vessel Occlusion Stroke During the Emergency Call: Protocol for a Controlled, Nonrandomized Trial
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be
- 16 April 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13 (1) , e58180
Open AccessCorrection: Identification of Anterior Large Vessel Occlusion Stroke During the Emergency Call: Protocol for a Controlled, Nonrandomized Trial
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be
- Open Access
- 8 March 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Correction: Identification of Anterior Large Vessel Occlusion Stroke During the Emergency Call: Protocol for a Controlled, Nonrandomized Trial (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
- 8 March 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessCorrection: Identification of Anterior Large Vessel Occlusion Stroke During the Emergency Call: Protocol for a Controlled, Nonrandomized Trial (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
- Open Access
- 13 February 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13 (1) , e51683
Identification of Anterior Large Vessel Occlusion Stroke During the Emergency Call: Protocol for a Controlled, Nonrandomized Trial
Background: Endovascular thrombectomy (ET), combined with intravenous thrombolysis if possible, is an effective treatment option for patients with stroke who have confirmed anterior large vessel occlusion (aLVO). However, ET is mainly limited to comprehensive stroke centers (CSCs), resulting in a lack of ET capacity in remote, sparsely populated areas. Most stroke networks use the “Drip and Ship” or “Mothership” strategy, resulting in either delayed ET or intravenous thrombolysis, respectively. Objective: This study protocol introduces the Leitstellen-Basierte Erkennung von Schlaganfall-Patienten für eine Thrombektomie und daraufhin abgestimmte Optimierung der Rettungskette (LESTOR) strategy, developed to optimize the preclinical part of the stroke chain of survival to improve the clinical outcome of patients with suspected aLVO stroke. This involves refining the dispatch strategy for identifying patients with acute aLVO stroke using a phone-based aLVO query. This includes dispatching emergency physicians and emergency medical services (EMS) to urban emergency sites, as well as dispatching helicopter EMS to remote areas. If a highly suspected aLVO is identified after a standardized aLVO score evaluation during a structured examination at the emergency scene, prompt transport to a CSC should be prioritized. Methods: The LESTOR study is a controlled, nonrandomized study implementing the LESTOR strategy, with a stepped-wedge, cluster trial design in 6 districts in southwest Germany. In an interprofessional, iterative approach, an aLVO query or dispatch protocol intended for use by dispatchers, followed by a coordinated aLVO examination score for use by EMS, is being developed, evaluated, and pretested in a simulation study. After the training of all participating health care professionals with the corresponding final aLVO query, the LESTOR strategy is being implemented stepwise. Patients otherwise receive usual stroke care in both the control and intervention groups. The primary outcome is the modified Rankin Scale at 90 days in patients with stroke receiving endovascular treatment. We will use a generalized linear mixed model for data analysis. This study is accompanied by a cost-effectiveness analysis and a qualitative process evaluation. Results: This paper describes and discusses the protocol for this controlled, nonrandomized LESTOR study. Enrollment was completed in June 2023. Data analysis is ongoing and the first results are expected to be submitted for publication in 2024. The project started in April 2020 and will end in February 2024. Conclusions: We expect that the intervention will improve the clinical outcome of patients with aLVO stroke, especially outside the catchment areas of CSCs. The results of the accompanying process evaluation and the cost-effectiveness analysis will provide further insights into the implementation process and allow for a better interpretation of the results. Trial Registration: German Clinical Trials Register DRKS00022152; https://drks.de/search/de/trial/DRKS00022152 International Registered Report Identifier (IRRID): DERR1-10.2196/51683
- 13 February 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13 (1) , e51683
Open AccessIdentification of Anterior Large Vessel Occlusion Stroke During the Emergency Call: Protocol for a Controlled, Nonrandomized Trial
Background: Endovascular thrombectomy (ET), combined with intravenous thrombolysis if possible, is an effective treatment option for patients with stroke who have confirmed anterior large vessel occlusion (aLVO). However, ET is mainly limited to comprehensive stroke centers (CSCs), resulting in a lack of ET capacity in remote, sparsely populated areas. Most stroke networks use the “Drip and Ship” or “Mothership” strategy, resulting in either delayed ET or intravenous thrombolysis, respectively. Objective: This study protocol introduces the Leitstellen-Basierte Erkennung von Schlaganfall-Patienten für eine Thrombektomie und daraufhin abgestimmte Optimierung der Rettungskette (LESTOR) strategy, developed to optimize the preclinical part of the stroke chain of survival to improve the clinical outcome of patients with suspected aLVO stroke. This involves refining the dispatch strategy for identifying patients with acute aLVO stroke using a phone-based aLVO query. This includes dispatching emergency physicians and emergency medical services (EMS) to urban emergency sites, as well as dispatching helicopter EMS to remote areas. If a highly suspected aLVO is identified after a standardized aLVO score evaluation during a structured examination at the emergency scene, prompt transport to a CSC should be prioritized. Methods: The LESTOR study is a controlled, nonrandomized study implementing the LESTOR strategy, with a stepped-wedge, cluster trial design in 6 districts in southwest Germany. In an interprofessional, iterative approach, an aLVO query or dispatch protocol intended for use by dispatchers, followed by a coordinated aLVO examination score for use by EMS, is being developed, evaluated, and pretested in a simulation study. After the training of all participating health care professionals with the corresponding final aLVO query, the LESTOR strategy is being implemented stepwise. Patients otherwise receive usual stroke care in both the control and intervention groups. The primary outcome is the modified Rankin Scale at 90 days in patients with stroke receiving endovascular treatment. We will use a generalized linear mixed model for data analysis. This study is accompanied by a cost-effectiveness analysis and a qualitative process evaluation. Results: This paper describes and discusses the protocol for this controlled, nonrandomized LESTOR study. Enrollment was completed in June 2023. Data analysis is ongoing and the first results are expected to be submitted for publication in 2024. The project started in April 2020 and will end in February 2024. Conclusions: We expect that the intervention will improve the clinical outcome of patients with aLVO stroke, especially outside the catchment areas of CSCs. The results of the accompanying process evaluation and the cost-effectiveness analysis will provide further insights into the implementation process and allow for a better interpretation of the results. Trial Registration: German Clinical Trials Register DRKS00022152; https://drks.de/search/de/trial/DRKS00022152 International Registered Report Identifier (IRRID): DERR1-10.2196/51683
- Open Access
Using the Built-in iPhone Body Tracking System for Neurological Tests: The Example of Assessing Arm Weakness in Stroke Patients. A Preliminary Evaluation of Accuracy and Performance
Timely treatment of stroke is critical to minimize brain damage. Therefore, efforts are being made to educate the public on detecting stroke symptoms, e.g., face, arms, and speech test (FAST). In this position paper, we propose to perform the arm weakness test using the integrated video tracking from an iPhone - some general tests to assess the tracking quality and discuss potential critical points. The test has been performed on 4 stroke patients. The result is compared with the report of the clinician. Although presenting some limitations, the system proved to be able to detect arm weakness as a symptom of stroke. We envisage that introducing a portable body tracking system in such clinical tests will provide advantages in terms of objectivity, repeatability, and the possibility to record and compare groups of patients.
Open AccessUsing the Built-in iPhone Body Tracking System for Neurological Tests: The Example of Assessing Arm Weakness in Stroke Patients. A Preliminary Evaluation of Accuracy and Performance
Timely treatment of stroke is critical to minimize brain damage. Therefore, efforts are being made to educate the public on detecting stroke symptoms, e.g., face, arms, and speech test (FAST). In this position paper, we propose to perform the arm weakness test using the integrated video tracking from an iPhone - some general tests to assess the tracking quality and discuss potential critical points. The test has been performed on 4 stroke patients. The result is compared with the report of the clinician. Although presenting some limitations, the system proved to be able to detect arm weakness as a symptom of stroke. We envisage that introducing a portable body tracking system in such clinical tests will provide advantages in terms of objectivity, repeatability, and the possibility to record and compare groups of patients.
- Open Access
- 9 August 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Identification of Anterior Large Vessel Occlusion Stroke During the Emergency Call: Protocol for a Controlled, Nonrandomized Trial (Preprint)
BACKGROUND Endovascular thrombectomy (ET), combined with intravenous thrombolysis if possible, is an effective treatment option for patients with stroke who have confirmed anterior large vessel occlusion (aLVO). However, ET is mainly limited to comprehensive stroke centers (CSCs), resulting in a lack of ET capacity in remote, sparsely populated areas. Most stroke networks use the “Drip and Ship” or “Mothership” strategy, resulting in either delayed ET or intravenous thrombolysis, respectively. OBJECTIVE This study protocol introduces the Leitstellen-Basierte Erkennung von Schlaganfall-Patienten für eine Thrombektomie und daraufhin abgestimmte Optimierung der Rettungskette (LESTOR) strategy, developed to optimize the preclinical part of the stroke chain of survival to improve the clinical outcome of patients with suspected aLVO stroke. This involves refining the dispatch strategy for identifying patients with acute aLVO stroke using a phone-based aLVO query. This includes dispatching emergency physicians and emergency medical services (EMS) to urban emergency sites, as well as dispatching helicopter EMS to remote areas. If a highly suspected aLVO is identified after a standardized aLVO score evaluation during a structured examination at the emergency scene, prompt transport to a CSC should be prioritized. METHODS The LESTOR study is a controlled, nonrandomized study implementing the LESTOR strategy, with a stepped-wedge, cluster trial design in 6 districts in southwest Germany. In an interprofessional, iterative approach, an aLVO query or dispatch protocol intended for use by dispatchers, followed by a coordinated aLVO examination score for use by EMS, is being developed, evaluated, and pretested in a simulation study. After the training of all participating health care professionals with the corresponding final aLVO query, the LESTOR strategy is being implemented stepwise. Patients otherwise receive usual stroke care in both the control and intervention groups. The primary outcome is the modified Rankin Scale at 90 days in patients with stroke receiving endovascular treatment. We will use a generalized linear mixed model for data analysis. This study is accompanied by a cost-effectiveness analysis and a qualitative process evaluation. RESULTS This paper describes and discusses the protocol for this controlled, nonrandomized LESTOR study. Enrollment was completed in June 2023. Data analysis is ongoing and the first results are expected to be submitted for publication in 2024. The project started in April 2020 and will end in February 2024. CONCLUSIONS We expect that the intervention will improve the clinical outcome of patients with aLVO stroke, especially outside the catchment areas of CSCs. The results of the accompanying process evaluation and the cost-effectiveness analysis will provide further insights into the implementation process and allow for a better interpretation of the results. CLINICALTRIAL German Clinical Trials Register DRKS00022152; https://drks.de/search/de/trial/DRKS00022152 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/51683
- 9 August 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessIdentification of Anterior Large Vessel Occlusion Stroke During the Emergency Call: Protocol for a Controlled, Nonrandomized Trial (Preprint)
BACKGROUND Endovascular thrombectomy (ET), combined with intravenous thrombolysis if possible, is an effective treatment option for patients with stroke who have confirmed anterior large vessel occlusion (aLVO). However, ET is mainly limited to comprehensive stroke centers (CSCs), resulting in a lack of ET capacity in remote, sparsely populated areas. Most stroke networks use the “Drip and Ship” or “Mothership” strategy, resulting in either delayed ET or intravenous thrombolysis, respectively. OBJECTIVE This study protocol introduces the Leitstellen-Basierte Erkennung von Schlaganfall-Patienten für eine Thrombektomie und daraufhin abgestimmte Optimierung der Rettungskette (LESTOR) strategy, developed to optimize the preclinical part of the stroke chain of survival to improve the clinical outcome of patients with suspected aLVO stroke. This involves refining the dispatch strategy for identifying patients with acute aLVO stroke using a phone-based aLVO query. This includes dispatching emergency physicians and emergency medical services (EMS) to urban emergency sites, as well as dispatching helicopter EMS to remote areas. If a highly suspected aLVO is identified after a standardized aLVO score evaluation during a structured examination at the emergency scene, prompt transport to a CSC should be prioritized. METHODS The LESTOR study is a controlled, nonrandomized study implementing the LESTOR strategy, with a stepped-wedge, cluster trial design in 6 districts in southwest Germany. In an interprofessional, iterative approach, an aLVO query or dispatch protocol intended for use by dispatchers, followed by a coordinated aLVO examination score for use by EMS, is being developed, evaluated, and pretested in a simulation study. After the training of all participating health care professionals with the corresponding final aLVO query, the LESTOR strategy is being implemented stepwise. Patients otherwise receive usual stroke care in both the control and intervention groups. The primary outcome is the modified Rankin Scale at 90 days in patients with stroke receiving endovascular treatment. We will use a generalized linear mixed model for data analysis. This study is accompanied by a cost-effectiveness analysis and a qualitative process evaluation. RESULTS This paper describes and discusses the protocol for this controlled, nonrandomized LESTOR study. Enrollment was completed in June 2023. Data analysis is ongoing and the first results are expected to be submitted for publication in 2024. The project started in April 2020 and will end in February 2024. CONCLUSIONS We expect that the intervention will improve the clinical outcome of patients with aLVO stroke, especially outside the catchment areas of CSCs. The results of the accompanying process evaluation and the cost-effectiveness analysis will provide further insights into the implementation process and allow for a better interpretation of the results. CLINICALTRIAL German Clinical Trials Register DRKS00022152; https://drks.de/search/de/trial/DRKS00022152 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/51683
- Open Access
- 1 September 2022
- Published by Springer Nature in Research Square
Improving the identification of large vessel occlusion stroke during the emergency call: Protocol for the controlled LESTOR study with a stepped-wedge design
BackgroundLarge vessel occlusions (LVO) cause up to 30% of acute ischemic strokes. Mechanical thrombectomy is the first line treatment performed by neurointerventionalists. In Germany, neurointerventionalists are mostly situated in comprehensive stroke centres (CSC). Thus, long transport distances to CSCs may be necessary. The aim of this study is to implement and evaluate an intervention that involves lay first responders in the early identification of LVO, followed by a direct assignment to a CSC.Methods This controlled study with a stepped-wedge design and clustering of six emergency control centres in southwest Germany will stepwise implement LVO screening performed during the emergency call. Individuals with suspected LVO in both the control and intervention group (n=250) will undergo the usual treatment. In addition, emergency medical service dispatchers will screen patients in the intervention group for cortical stroke symptoms. For those with suspected LVO, air rescue is initiated immediately by the dispatchers. If the emergency medical service on scene confirms the suspected LVO, the patient benefits from accelerated transportation to the CSC. The primary endpoint is the clinical outcome measured by the modified Rankin Scale 90 days post-stroke. In addition, we will perform a qualitative process evaluation.Discussion We will assess the feasibility and cost-effectiveness of a systematic screening for symptoms of acute LVO implemented at the emergency control centre. The process evaluation will provide additional insight into how the participating emergency professionals perceive the intervention and the psychological impact on lay first responders. We hypothesize that early, pre-hospital identification of LVO patients and an optimized rescue chain will enable earlier treatment - especially in rural areas. We expect improved clinical outcomes of LVO patients and a better understanding for future studies with larger sample sizes.Trial registrationDRKS (German Clinical Trials Register), DRKS-ID: DRKS00022152. Registered 19th October 2020, https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022152; WHO UTN: U1111-1253-5758.
- 1 September 2022
- Published by Springer Nature in Research Square
Open AccessImproving the identification of large vessel occlusion stroke during the emergency call: Protocol for the controlled LESTOR study with a stepped-wedge design
BackgroundLarge vessel occlusions (LVO) cause up to 30% of acute ischemic strokes. Mechanical thrombectomy is the first line treatment performed by neurointerventionalists. In Germany, neurointerventionalists are mostly situated in comprehensive stroke centres (CSC). Thus, long transport distances to CSCs may be necessary. The aim of this study is to implement and evaluate an intervention that involves lay first responders in the early identification of LVO, followed by a direct assignment to a CSC.Methods This controlled study with a stepped-wedge design and clustering of six emergency control centres in southwest Germany will stepwise implement LVO screening performed during the emergency call. Individuals with suspected LVO in both the control and intervention group (n=250) will undergo the usual treatment. In addition, emergency medical service dispatchers will screen patients in the intervention group for cortical stroke symptoms. For those with suspected LVO, air rescue is initiated immediately by the dispatchers. If the emergency medical service on scene confirms the suspected LVO, the patient benefits from accelerated transportation to the CSC. The primary endpoint is the clinical outcome measured by the modified Rankin Scale 90 days post-stroke. In addition, we will perform a qualitative process evaluation.Discussion We will assess the feasibility and cost-effectiveness of a systematic screening for symptoms of acute LVO implemented at the emergency control centre. The process evaluation will provide additional insight into how the participating emergency professionals perceive the intervention and the psychological impact on lay first responders. We hypothesize that early, pre-hospital identification of LVO patients and an optimized rescue chain will enable earlier treatment - especially in rural areas. We expect improved clinical outcomes of LVO patients and a better understanding for future studies with larger sample sizes.Trial registrationDRKS (German Clinical Trials Register), DRKS-ID: DRKS00022152. Registered 19th October 2020, https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022152; WHO UTN: U1111-1253-5758.
- Open Access
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 4, 198
Hypokinesia upon Pallidal Deep Brain Stimulation of Dystonia: Support of a GABAergic Mechanism
In the past, many studies have documented the beneficial effects of deep brain stimulation (DBS) in the globus pallidus internus for treatment of primary segmental or generalized dystonia. Recently however, several reports focused on DBS-induced hypokinesia or freezing of gait as a side effect in these patients. Here we report on two patients suffering from freezing of gait after successful treatment of their dystonic movement disorder with pallidal high frequency stimulation (HFS). Several attempts to reduce the freezing of gait resulted in worsening of the control of dystonia. In one patient levodopa treatment was initialized which was somewhat successful to relieve freezing of gait. We discuss the possible mechanisms of hypokinetic side effects of pallidal DBS which can be explained by the hypothesis of selective GABA release as the mode of action of HFS. Pallidal HFS is also effective in treating idiopathic Parkinson’s disease as a hypokinetic disorder which at first sight seems to be a paradox. In our view, however, the GABAergic hypothesis can explain this and other clinical observations.
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 4, 198
Open AccessHypokinesia upon Pallidal Deep Brain Stimulation of Dystonia: Support of a GABAergic Mechanism
In the past, many studies have documented the beneficial effects of deep brain stimulation (DBS) in the globus pallidus internus for treatment of primary segmental or generalized dystonia. Recently however, several reports focused on DBS-induced hypokinesia or freezing of gait as a side effect in these patients. Here we report on two patients suffering from freezing of gait after successful treatment of their dystonic movement disorder with pallidal high frequency stimulation (HFS). Several attempts to reduce the freezing of gait resulted in worsening of the control of dystonia. In one patient levodopa treatment was initialized which was somewhat successful to relieve freezing of gait. We discuss the possible mechanisms of hypokinetic side effects of pallidal DBS which can be explained by the hypothesis of selective GABA release as the mode of action of HFS. Pallidal HFS is also effective in treating idiopathic Parkinson’s disease as a hypokinetic disorder which at first sight seems to be a paradox. In our view, however, the GABAergic hypothesis can explain this and other clinical observations.
- Open Access
- 10 December 2012
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 12 (1) , 344
CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings
Current guidelines regarding Lyme neuroborreliosis [LNB] require the presence of intrathecal Borrelia burgdorferi-specific antibody production for the definite diagnosis of LNB. However, about 20% of early stage infections present without an elevated antibody index. Moreover, intrathecal B. burgdorferi specific antibody synthesis may persist long after successful therapy of LNB. Recently published data indicate that CXCL13 seems to be a promising diagnostic tool for early stage LNB. In addition, CXCL13 might be suitable for treatment monitoring.
- 10 December 2012
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 12 (1) , 344
Open AccessCXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings
Current guidelines regarding Lyme neuroborreliosis [LNB] require the presence of intrathecal Borrelia burgdorferi-specific antibody production for the definite diagnosis of LNB. However, about 20% of early stage infections present without an elevated antibody index. Moreover, intrathecal B. burgdorferi specific antibody synthesis may persist long after successful therapy of LNB. Recently published data indicate that CXCL13 seems to be a promising diagnostic tool for early stage LNB. In addition, CXCL13 might be suitable for treatment monitoring.